PRINCIPAL FINANCIAL GROUP INC - CTI BIOPHARMA CORP ownership

CTI BIOPHARMA CORP's ticker is CTICXXXX and the CUSIP is 12648L106. A total of 94 filers reported holding CTI BIOPHARMA CORP in Q4 2015. The put-call ratio across all filers is 0.41 and the average weighting 0.3%.

Quarter-by-quarter ownership
PRINCIPAL FINANCIAL GROUP INC ownership history of CTI BIOPHARMA CORP
ValueSharesWeighting
Q1 2016$21,000
-43.2%
40,323
+35.3%
0.00%
Q4 2015$37,000
-9.8%
29,809
+7.1%
0.00%
Q3 2015$41,000
-49.4%
27,836
-37.4%
0.00%
Q1 2015$81,000
-9.0%
44,501
+17.7%
0.00%
Q4 2014$89,000
-17.6%
37,810
-14.9%
0.00%
Q3 2014$108,000
-13.6%
44,4520.0%0.00%
Q2 2014$125,00044,4520.00%
Other shareholders
CTI BIOPHARMA CORP shareholders Q4 2015
NameSharesValueWeighting ↓
FIRST NEW YORK SECURITIES LLC /NY 191,000$345,710,0000.34%
TFS CAPITAL LLC 1,182,304$2,140,0000.21%
TURNER INVESTMENTS LLC 530,100$959,0000.17%
DRW Securities, LLC 486,953$881,0000.14%
Candriam S.C.A. 1,445,000$2,616,0000.05%
First Heartland Consultants, Inc. 74,624$135,0000.05%
WASHINGTON TRUST Co 410,616$743,0000.05%
EAGLE ASSET MANAGEMENT INC 4,332,630$7,842,0000.04%
JW Asset Management, LLC 52,271$95,0000.04%
OXFORD ASSET MANAGEMENT LLP 702,571$1,272,0000.03%
View complete list of CTI BIOPHARMA CORP shareholders